Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance
- PMID: 1323124
- PMCID: PMC49642
- DOI: 10.1073/pnas.89.15.7046
Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance
Abstract
As previously described, proliferation of Kaposi sarcoma (KS)-derived cells in vitro is dependent on the presence of platelet-derived growth factor (PDGF). To test the hypothesis that PDGF may also be a major growth factor for KS cells in vivo, we performed in situ hybridization and immunohistochemical staining for PDGF and PDGF receptors in tissue sections of AIDS-related KS. The data suggest that KS consists of two types of tumor cells. (i) The main population are spindle-shaped cells with elongated nuclei (KS-s cells). They reveal a strong expression of PDGF beta receptors but do not express the PDGF-A and PDGF-B isoforms. (ii) A minor population of KS cells express PDGF beta receptor as well as PDGF-A and PDGF-B (KS-p cells). These cells are often grouped in whorls and surrounding vascular slits. They reveal spherical nuclei with evenly distributed chromatin and inconspicuous nucleoli. PDGF alpha receptor is not expressed in either form of KS cells. The results suggest that the isoforms of PDGF and the PDGF beta receptor are differentially expressed in two different cell types in KS and that PDGF isoforms may contribute to the pathogenesis of KS.
Similar articles
-
Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system.Cancer Res. 1992 Feb 15;52(4):1006-12. Cancer Res. 1992. PMID: 1310635
-
Cultured Kaposi's sarcoma-derived cells express functional PDGF A-type and B-type receptors.Exp Cell Res. 1990 Mar;187(1):98-103. doi: 10.1016/0014-4827(90)90122-q. Exp Cell Res. 1990. PMID: 2153568
-
Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis.Oncogene. 1995 May 18;10(10):2007-16. Oncogene. 1995. PMID: 7761101
-
Kaposi's sarcoma: its 'oncogenes' and growth factors.Crit Rev Oncol Hematol. 1991;11(2):87-107. doi: 10.1016/1040-8428(91)90001-s. Crit Rev Oncol Hematol. 1991. PMID: 1657029 Review.
-
Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science.J Cell Physiol. 2006 Dec;209(3):659-62. doi: 10.1002/jcp.20795. J Cell Physiol. 2006. PMID: 17001705 Review.
Cited by
-
KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis.PLoS Pathog. 2018 Jul 9;14(7):e1007175. doi: 10.1371/journal.ppat.1007175. eCollection 2018 Jul. PLoS Pathog. 2018. PMID: 29985958 Free PMC article.
-
Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma.J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):64-8. doi: 10.1097/QAI.0b013e3181fc0141. J Acquir Immune Defic Syndr. 2011. PMID: 21068672 Free PMC article. Clinical Trial.
-
HIV-1 Tat-mediated induction of platelet-derived growth factor in astrocytes: role of early growth response gene 1.J Immunol. 2011 Apr 1;186(7):4119-29. doi: 10.4049/jimmunol.1002235. Epub 2011 Mar 2. J Immunol. 2011. PMID: 21368226 Free PMC article.
-
Treatment for Kaposi sarcoma herpesvirus: great challenges with promising accomplishments.Virus Genes. 2009 Apr;38(2):195-203. doi: 10.1007/s11262-008-0325-y. Epub 2009 Jan 13. Virus Genes. 2009. PMID: 19139983 Review.
-
Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC.Lung Cancer. 2017 Sep;111:108-115. doi: 10.1016/j.lungcan.2017.07.009. Epub 2017 Jul 18. Lung Cancer. 2017. PMID: 28838379 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials